Abstract
BackgroundMeningococcal disease is caused by the bacteria Neisseria meningitidis, leading to substantial mortality and severe morbidity; with serogroups A, B, C, W135, X and Y most significant in causing disease. An outbreak is defined as multiple cases of the same serogroup occurring in a population over a short time-period. A systematic review was performed to gain insight into outbreaks of meningococcal disease and to describe the temporal pattern over the last 50 years in non-African countries.MethodsPubMed and EMBASE were searched for English-language publications on outbreaks of meningococcal disease in non-African countries between January 1966 and July 2017, with an additional grey literature search. Articles and reports were considered eligible if they reported confirmed meningococcal outbreak cases, included the region, number of cases, and the start and end dates of the outbreak. Data on outbreaks was stratified by geographical region in accordance with the World Health Organization (WHO) regional classification, and case-fatality rates (CFRs) were calculated.ResultsOf the identified publications, 3067 were screened and 73 included, reporting data from 83 outbreaks. The majority of outbreaks were identified in the regions of the Americas (41/83 outbreaks), followed by the European region (30/83 outbreaks). In each of the Western Pacific, Eastern Mediterranean, and South-East Asian regions there were <10 outbreaks reported. The predominant serogroup in the majority of outbreaks was serogroup C (61%), followed by serogroup B (29%), serogroup A (5%) and serogroup W135 (4%). Outbreaks showed a peak in the colder months of both the Northern and Southern Hemispheres. Of the 54 outbreaks where CFR was calculable for all outbreak cases, it ranged from 0%-80%.ConclusionsThese data present a retrospective view of the patterns for meningococcal disease outbreaks in non-African countries, and provide valuable data for monitoring future changes in disease epidemiology and informing preventive measures.
Highlights
Hits from ProMED mail were first screened based on title and abstract, followed by full-text screening
Outbreak Ib: October 2001– December 2001 Outbreak II: September– December 2004 MCD cases identified during outbreak among MSM in a city
MCD cases identified during 2 outbreaks in a hotel resort and a nursing home
Summary
MCD cases identified during Laboratory outbreak in 2 contiguous rural confirmed counties n=5 Age range: 17–39 yrs Male: 100%. Outbreak I Chemoprophylaxis (rifampin): - After case 1-3, all guests and employees at both hotels - After 5th case, all guests and employees at hotel A. Outbreak II Chemoprophylaxis (ciprofloxacin): - All persons who had visited the facility during the previous 14 days (staff members, patients, visitors). Vaccination NR Chemoprophylaxis (minocycline): - Basic combat trainees - Training cadre Chemoprophylaxis (minocycline): - Untreated recruits. Vaccination (group C polysaccharide vaccine): - All recruits in the first 6 weeks of basic training and to all inductees entering Fort Lewis Chemoprophylaxis (type NR): - Household contacts of cases 1–3 Chemoprophylaxis (rifampin): - Persons who lived in the residence of case 4 or who had had close contact with the patient. Vaccination NR Chemoprophylaxis (rifampin for prophylaxis): - All household contacts. Chemoprophylaxis (sulfamethoxazole): - School children and their household contacts
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
